Emma McErlean
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 7
- Advanced biosensing and bioanalysis techniques 4
- Oncology 5
- Peptidase Inhibition and Analysis 2
- Bone health and treatments 2
- Co-authors
- Helen O. McCarthy (13 shared papers)Cian M. McCrudden (6 shared papers)Nicholas Dunne (8 shared papers)Tracy Robson (6 shared papers)Victoria Kett (5 shared papers)Joanne McCaffrey (3 shared papers)Grace Cole (3 shared papers)Monika Ziminska (2 shared papers)
- Journals
- Journal of Nanobiotechnology (2 papers)Journal of Controlled Release (2 papers)International Journal of Pharmaceutics (2 papers)Molecular Pharmaceutics (1 paper)Drug Delivery and Translational Research (1 paper)
- Partner nations
- United KingdomIrelandJordan
In The Last Decade
Emma McErlean
14 papers receiving 448 citations
Peers
Comparison fields: 5 of 65
- Biomaterials 137
- Pharmaceutical Science 61
- Molecular Medicine 23
- Dermatology 29
- Immunology 68
Countries citing papers authored by Emma McErlean
This map shows the geographic impact of Emma McErlean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma McErlean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma McErlean more than expected).
Fields of papers citing papers by Emma McErlean
This network shows the impact of papers produced by Emma McErlean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma McErlean. The network helps show where Emma McErlean may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma McErlean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 125 | |
| 2 | 2019 | 85 | |
| 3 | 2020 | 44 | |
| 4 | 2020 | 41 | |
| 5 | 2016 | 33 | |
| 6 | 2018 | 32 | |
| 7 | 2016 | 25 | |
| 8 | 2021 | 20 | |
| 9 | 2024 | 14 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 6 | |
| 13 | 2025 | 4 | |
| 14 | 2024 | 3 |
About Emma McErlean
Emma McErlean is a scholar working on Molecular Biology, Oncology, Genetics, Biomaterials and Immunology, having authored 14 papers that have together received 448 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (4 papers), Virus-based gene therapy research (4 papers), Peptidase Inhibition and Analysis (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Bone health and treatments (2 papers), Electrospun Nanofibers in Biomedical Applications (1 paper) and Polymer Surface Interaction Studies (1 paper). The work is most often cited by research in Biomaterials (137 citations), Pharmaceutical Science (61 citations), Molecular Medicine (23 citations), Dermatology (29 citations) and Immunology (68 citations). Emma McErlean has collaborated with scholars based in United Kingdom, Ireland and Jordan. Frequent co-authors include Helen O. McCarthy, Cian M. McCrudden, Nicholas Dunne, Tracy Robson, Victoria Kett, Joanne McCaffrey, Grace Cole, Monika Ziminska, J.W. McBride and Eoghan J. Mulholland. Their work appears in journals such as Journal of Nanobiotechnology, Journal of Controlled Release, International Journal of Pharmaceutics, Molecular Pharmaceutics and Drug Delivery and Translational Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.